tiprankstipranks
Trending News
More News >
Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE
US Market

Sorrento Therapeutics (SRNE) Income Statement

Compare
5,243 Followers

Sorrento Therapeutics Income Statement

Last quarter (Q2 2023), Sorrento Therapeutics's total revenue was $15.03M, an increase of 31.10% from the same quarter last year. In Q2, Sorrento Therapeutics's net income was $-95.21M. See Sorrento Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 62.84M$ 52.90M$ 39.99M$ 31.43M$ 21.19M
Gross Profit
$ 29.39M$ 39.87M$ 30.05M$ 19.20M$ 11.12M
Operating Expenses
$ 533.70M$ 407.92M$ 231.57M$ 214.38M$ 140.60M
Depreciation and Amortization
$ 13.24M$ 16.32M$ 14.71M$ 15.04M$ 9.05M
EBITDA
$ -539.93M$ -435.99M$ -275.69M$ -308.39M$ -147.10M
Operating Income
$ -504.31M$ -368.05M$ -201.53M$ -195.18M$ -129.48M
Other Income/Expenses
$ -57.43M$ -94.48M$ -114.90M$ -100.18M$ -63.36M
Pretax Income
$ -561.75M$ -462.53M$ -316.42M$ -359.58M$ -213.78M
Net Income
$ -572.84M$ -429.01M$ -298.46M$ -359.10M$ -203.54M
Per Share Metrics
Basic EPS
$ -1.37$ -1.46$ -1.30$ -2.56$ -1.92
Diluted EPS
$ -1.37$ -1.46$ -1.30$ -2.56$ -1.92
Weighted Average Shares Outstanding
419.31M 294.77M 229.82M 140.51M 106.15M
Weighted Average Shares Outstanding (Diluted)
419.31M 294.77M 229.82M 140.51M 106.15M
Currency in USD

Sorrento Therapeutics Earnings and Revenue History